Effects of Tamoxifen Administration on Lipid Profile in Female Albino Rats

References (29)

1. 1 Colorimetric determination of phospholipids with ammonium ferrothiocyanate [DOI]
2. 2 Improved procedure for the extraction of lipids from human erythrocytes [DOI]
3. 3 Tamoxifen: a most unlikely pioneering medicine [DOI]
4. 4 Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure [DOI]
5. 5 Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6 [DOI]
6. 6 Lipid Metabolism and Toxicity in the Heart [DOI]
7. 7 Drugs and Steatohepatitis [DOI]
8. 8 A Toxicogenomic Approach to Drug-Induced Phospholipidosis: Analysis of Its Induction Mechanism and Establishment of a Novel in Vitro Screening System [DOI]
9. 9 Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women [DOI]
10. 10 Current understanding of the metabolism and biological actions of HDL [DOI]
11. 11 Cardiac lipoprotein lipase: Metabolic basis for diabetic heart disease [DOI]
12. 12 Oxidative stress leads to cholesterol accumulation in vascular smooth muscle cells [DOI]
13. 13 Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen [DOI]
14. 14 Comparative assessment of lipid effects of endocrine therapy for breast cancer: Implications for cardiovascular disease prevention in postmenopausal women [DOI]
15. 15 Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver [DOI]
16. 16 Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids [DOI]
17. 17 Lead nitrate-induced development of hypercholesterolemia in rats: sterol-independent gene regulation of hepatic enzymes responsible for cholesterol homeostasis [DOI]
18. 18 A Role for Lysosomal Phospholipase A2 in Drug Induced Phospholipidosis [DOI]
19. 19 Multiple Indexes of Lipid Availability Are Independently Related to Whole Body Insulin Action in Healthy Humans [DOI]
20. 20 Adjuvant Tamoxifen Influences the Lipid Profile in Breast Cancer Patients [DOI]
21. 21 Tissue dyslipidemia in salmonella-infected rats treated with amoxillin and pefloxacin [DOI]
22. 22 Tamoxifen Treatment in Danish Breast Cancer Patients and 5-Year Risk of Arterial Atherosclerotic Events: A Null Association [DOI]
23. 23 Lipoprotein lipase-derived fatty acids: Physiology and dysfunction [DOI]
24. 24 Amoxillin- and pefloxacin-induced cholesterogenesis and phospholipidosis in rat tissues [DOI]
25. 25 The effect of zinc deficiency on erythrocyte membrane lipids of force-fed rats receiving a diet containing coconut oil or fish oil.
26. 26 90244353 Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer [DOI]
27. 27 Lipids in Health and Disease
28. 28 Decreased hepatic production of very low density lipoproteins following activation of fatty acid oxidation by Ro 22-0654. [DOI]
29. 29 Molecular and Cellular Biochemistry

Cited by 10

Showing 5 of 10 known citations — external sources report more than can currently be individually listed.

Related research

• Formulation Development, Characterization and In-vitro Evaluation of Tamoxifen Loaded Liposomes — shares topic coverage
• Unravelling Tamoxifen’s Neuroprotective Effects against Manganese-Induced Neurodegeneration, Cognitive Impairment and Hippocampal Damage Via the Nrf-2 Pathway in Adult Male Wistar Rats — shares topic coverage
• Anti-Cancer Effect of Novel Hydroxy Flavons on Human Cancer Cell In vitro and In silico — shares topic coverage
• The Antiangiogenic Effects of Tamoxifen might be Attributed to Receptor Binding Capacity of its Solvent Dimethylsulfoxide in Breast Cancer: A Molecular Docking Study — shares topic coverage